Page last updated: 2024-09-05

3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Lung Neoplasms

3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gorbunova, VA; Kuz'minov, AE; Naskhletashvili, DR1

Reviews

1 review(s) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Lung Neoplasms

ArticleYear
[Combination chemotherapy with newly-developed cytostatics for disseminated small cell lung cancer].
    Voprosy onkologii, 2007, Volume: 53, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Glycosides; Humans; Irinotecan; Lung Neoplasms; Male; Methylnitrosourea; Middle Aged; Taxoids; Treatment Outcome

2007